 Kidney Neoplasms
"Kidney Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the KIDNEY.
| Descriptor ID |
D007680
|
| MeSH Number(s) |
C04.588.945.947.535 C12.758.820.750 C12.777.419.473 C13.351.937.820.535 C13.351.968.419.473
|
| Concept/Terms |
Kidney Neoplasms- Kidney Neoplasms
- Kidney Neoplasm
- Neoplasm, Kidney
- Renal Neoplasms
- Neoplasm, Renal
- Neoplasms, Renal
- Renal Neoplasm
- Neoplasms, Kidney
Cancer of Kidney- Cancer of Kidney
- Kidney Cancers
- Renal Cancer
- Cancer, Renal
- Cancers, Renal
- Renal Cancers
- Cancer of the Kidney
- Kidney Cancer
- Cancer, Kidney
- Cancers, Kidney
|
Below are MeSH descriptors whose meaning is more general than "Kidney Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Kidney Neoplasms".
This graph shows the total number of publications written about "Kidney Neoplasms" by people in this website by year, and whether "Kidney Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 2 | 0 | 2 | | 1982 | 0 | 2 | 2 | | 1983 | 2 | 0 | 2 | | 1984 | 1 | 0 | 1 | | 1985 | 2 | 2 | 4 | | 1986 | 2 | 1 | 3 | | 1988 | 3 | 0 | 3 | | 1989 | 2 | 0 | 2 | | 1990 | 1 | 0 | 1 | | 1991 | 4 | 0 | 4 | | 1992 | 4 | 0 | 4 | | 1993 | 3 | 1 | 4 | | 1994 | 5 | 1 | 6 | | 1995 | 3 | 0 | 3 | | 1996 | 1 | 1 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 10 | 0 | 10 | | 1999 | 7 | 0 | 7 | | 2000 | 13 | 0 | 13 | | 2001 | 8 | 2 | 10 | | 2002 | 9 | 2 | 11 | | 2003 | 8 | 2 | 10 | | 2004 | 22 | 0 | 22 | | 2005 | 14 | 4 | 18 | | 2006 | 23 | 5 | 28 | | 2007 | 20 | 4 | 24 | | 2008 | 22 | 0 | 22 | | 2009 | 24 | 1 | 25 | | 2010 | 20 | 4 | 24 | | 2011 | 9 | 1 | 10 | | 2012 | 9 | 1 | 10 | | 2013 | 15 | 2 | 17 | | 2014 | 17 | 2 | 19 | | 2015 | 12 | 0 | 12 | | 2016 | 19 | 1 | 20 | | 2017 | 10 | 1 | 11 | | 2018 | 13 | 1 | 14 | | 2019 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Kidney Neoplasms" by people in Profiles.
-
Rini BI, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, Bracarda S, Stadler WM, Donskov F, Lee JL, Hawkins R, Ravaud A, Alekseev B, Staehler M, Uemura M, De Giorgi U, Mellado B, Porta C, Melichar B, Gurney H, Bedke J, Choueiri TK, Parnis F, Khaznadar T, Thobhani A, Li S, Piault-Louis E, Frantz G, Huseni M, Schiff C, Green MC, Motzer RJ. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. Lancet. 2019 06 15; 393(10189):2404-2415.
-
Osterberg EC, Golan S, Pes MPL, Eggener SE, Petrut B, Singh SK, Sountoulides P, Türkeri LN, Wolf JS. International and Multi-institutional Assessment of Factors Associated With Performance and Quality of Lymph Node Dissection During Radical Nephrectomy. Urology. 2019 Jul; 129:132-138.
-
Patel HD, Puligandla M, Shuch BM, Leibovich BC, Kapoor A, Master VA, Drake CG, Heng DY, Lara PN, Choueiri TK, Maskens D, Singer EA, Eggener SE, Svatek RS, Stadler WM, Cole S, Signoretti S, Gupta RT, Michaelson MD, McDermott DF, Cella D, Wagner LI, Haas NB, Carducci MA, Harshman LC, Allaf ME. The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? Future Oncol. 2019 May; 15(15):1683-1695.
-
Pierorazio P, Eggener S. Obscenity, Michael Jordan, and Measuring Outcomes: Explaining and Improving the Quality of Kidney Cancer Care. Eur Urol. 2019 04; 75(4):635-636.
-
Andeen NK, Qu X, Antic T, Tykodi SS, Fang M, Tretiakova MS. Clinical Utility of Chromosome Genomic Array Testing for Unclassified and Advanced-Stage Renal Cell Carcinomas. Arch Pathol Lab Med. 2019 04; 143(4):494-504.
-
Crona DJ, Skol AD, Leppänen VM, Glubb DM, Etheridge AS, Hilliard E, Peña CE, Peterson YK, Klauber-DeMore N, Alitalo KK, Innocenti F. Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib. Cancer Res. 2019 01 01; 79(1):231-241.
-
Jester R, Znoyko I, Garnovskaya M, Rozier JN, Kegl R, Patel S, Tran T, Abedalthagafi M, Horbinski CM, Richardson M, Wolff DJ, Lapadat R, Moore W, Rodriguez FJ, Mull J, Olar A. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls. Acta Neuropathol Commun. 2018 10 19; 6(1):107.
-
Barata PC, Mendiratta P, Kotecha R, Gopalakrishnan D, Juloori A, Chao ST, Koshkin V, Ornstein M, Gilligan TD, Wood LS, Rini BI, Angelov L, Garcia JA. Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2018 10; 16(5):413-419.e1.
-
Parilla M, Kadri S, Patil SA, Ritterhouse L, Segal J, Henriksen KJ, Antic T. Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations? Am J Surg Pathol. 2018 07; 42(7):911-917.
-
Pal SK, Bergerot P, Dizman N, Bergerot C, Adashek J, Madison R, Chung JH, Ali SM, Jones JO, Salgia R. Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma. Eur Urol. 2018 07; 74(1):124-128.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|